Their important effects on high density lipoprotein levels, atherogenesis, oxidation, thrombosis, platelets, clotting factors and fibrinolysis are discussed.doi:10.1002/9781444318456.ch45Giovanni de GaetanoJohn Paul II Center for High Technology Research and, Education in Biomedical Sciences, Catholic ...
Risk factors for arterial thrombosis in antiphospholipid syn- drome. Thromb Res 2014 Feb; 133 (2): 173-6.Matyja Bednarczyk A; Swadzba J; Iwaniec T;.Risk fac- tors for arterial thrombosis in antiphospholipid syndrome.Thromb Res.2014.173-176...
Since the early 1990s attempts have been made to elucidate whether high concentrations of von Willebrand factor (VWF) and factor VIII (FVIII) in plasma are associated with an increased risk of thrombosis. Several prospective studies on the role of VWF in arterial thrombosis, mainly coronary heart...
Purpose Our prior work demonstrated Bleeding and thrombosis events (BTEs) are common in adult patients supported with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) but risk factors for these complications are not well understood. Methods We queried the Extracorporeal Life Support ...
In conclusion, considering its prevalence, non-O blood group is a candidate to be one of the most important genetic risk factors for venous thrombosis... Dentali,Francesco - 《Seminars in Thrombosis & Hemostasis》 被引量: 113发表: 2012年 Cerebral thrombosis, cerebral haemorrhage, and ABO blood...
Conclusions Female sex and metabolic disease may be factors contributing to hepatic artery thrombosis after living-donor liver transplantation. More intensive anticoagulation therapy for this patient population might decrease the incidence of hepatic artery thrombosis and, thus, posttransplant recipient ...
Data on characteristics and outcomes of coronavirus (COVID)-19 patients complicated with arterial thrombosis (AT) are scarce. Therefore, we carried out a systematic review (PRISMA, PROSPERO statements; PubMed, Scopus, and Web of Science) to identify risk factors, clinical presentation, treatment, ...
2005. von Willebrand factor and factor viii as risk factors for arterial and venous thrombosis. In: Mannucci PM editor, Seminars in Hematology. New York... Ida,Martinelli - 《Seminars in Hematology》 被引量: 139发表: 2005年 von Willebrand Factor ( 1999 ) Von Willebrand Factor . In: Labora...
Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between ... Antiphospholipid antibodies (aPL) characterize patients at risk for both arterial and venous thrombotic complications. Recently it has been recognized...
Among young individuals, up to age 40, venous thrombosis is the most common form of thrombosis. The risk factors for arterial and venous thrombosis differ, and among the latter disorders of hemostasis appear to be more prominent. In children venous thrombosis appears almost exclusively in ...